Testavan 23 mg, Gel

7680668160013 CH-66816 Gel

Associated product:

TESTAVAN gel 23 mg fl dos 85.5 g
Testavan 23 mg, Gel
Testavan 23 mg, Gel
Testavan 23 mg, Gel
1 / 3
google

Article details

Package size
85,5
Selling units
85
Measure
g
Galenic form
Gel
Galenic group
Salben

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/07/2021
Patient information leaflet
Français
02/07/2021
Patient information leaflet
Italien
02/07/2021
Summary of Product Characteristics
Allemand
02/07/2021
Summary of Product Characteristics
Français
02/07/2021
Summary of Product Characteristics
Italien
02/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
1.71 G Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Authorization holder

Future Health Pharma GmbH

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
66816
Drug name
Testavan, Gel
Galenic form
GELK
ATC Code
G03BA03
Authorization status
Z
Dispensing category
B
First authorization
12/06/2019
Authorization expiration date
31/12/9999
IT Number
07.08.4.
Domain
Human medicine
Field of application
Männlicher Hypogonadismus

Package details

Description (FR)
TESTAVAN gel 23 mg fl dos 85.5 g
Description (DE)
TESTAVAN Gel 23 mg Dosierfl 85.5 g
Market launch
12/06/2019
Narcotic (BTM)
No

Available generics (2)

Testosteron-Mepha, Injektionslösung
GTIN: 7680689890012
CHF 77.20
View
Testosteron Spirig HC, Injektionslösung
GTIN: 7680689760025
CHF 77.20
View